Anokion is focused on applying the company’s antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases. As a platform technology, Anokion’s approach to antigen-specific tolerance can be translated to virtually any protein in numerous clinical indications.
Anokion is seeking an experienced and highly-motivated immunologist to lead an exceptional team of scientists and advance our proprietary immunomodulatory platform technologies in support of the company’s clinical goals. The primary focus of this position will be to translate the findings of target pathway biology studies and pre-clinical models toward the development of immune assays that address clinical hypotheses. This role will be responsible for leading the development of translational PBMC-based clinical biomarker assays to support patient stratification and treatment response in immune therapy clinical trials. This individual should be a collaborative-minded, well-organized, and detail-oriented individual interested in contributing to excellent research science in an agile and dynamic team environment. The successful candidate will also provide immunology SME input into the writing and review of regulatory submissions, collaboration communications, and intellectual property filings.
Responsibilities and Duties
Qualifications and Skills